Enhancing Patient Safety In Acute Care: A Review Of The Integration Between Medical Device Technology, Pharmaceutical Systems, And Emergency Response Protocols

Abstract

Background: Preventable patient harm affects approximately one in ten hospitalized patients, often resulting from fragmented medical systems that rely on manual data entry and intermittent monitoring. This "siloed" approach creates informational blind spots that compromise safety. Integrated systems, combining smart infusion pumps, Electronic Health Records (EHR), and automated Early Warning Systems (EWS), offer a "closed-loop" solution to these structural hazards.   

Objective: This systematic review compares the effectiveness of integrated interoperable systems versus non-integrated manual systems on patient safety outcomes, specifically focusing on medication errors, clinical deterioration events, and mortality in acute care settings.

Methods: We conducted a systematic review following PRISMA 2020 guidelines, searching PubMed, CINAHL, and Cochrane Library for studies published between 2010 and 2023. The PICO framework was used to select studies involving acute care inpatients (P) managed with EHR-integrated devices or automated alerts (I) compared to standard manual care (C). Key outcomes included in-hospital cardiac arrests, mortality, and medication administration errors (O).   

Results: Thirty-six studies were included, with a meta-analysis of automated alert systems covering 349,818 participants. Results indicate that smart pump interoperability reduces overall medication administration errors by 16% to 21.2% and high-risk medication errors by approximately 47%. Automated EWS significantly reduced in-hospital cardiac arrests (Risk Ratio 0.60; 95% CI 0.43–0.85). While individual large-scale implementations demonstrated mortality benefits, pooled analysis showed no statistically significant reduction in overall hospital mortality (Risk Ratio 0.80). Secondary benefits included >95% drug library compliance and improved revenue capture.   

Conclusion: The integration of medical devices with pharmaceutical and emergency response protocols significantly reduces high-harm events, particularly cardiac arrests and critical medication errors. While mortality data remains heterogeneous, the transition to automated surveillance and interoperability standards like HL7 FHIR is critical for advancing patient safety.